Can Epigenetic Age Be Reversed?

Can Epigenetic Age Be Reversed?

Current evidence suggests that epigenetic age can be partially influenced — and in some experimental settings, reduced — but this is not the same as reversing biological ageing in a clinically proven sense. Epigenetic clocks can shift in response to specific interventions, and some human studies have recorded reductions in measured epigenetic age. However, what those shifts mean for long-term health and lifespan remains an open question that science has not yet fully answered.

What Is Epigenetic Age and How Is It Measured?

Epigenetics and the Ageing Process

Epigenetics refers to chemical modifications that regulate how genes are expressed, without altering the underlying DNA sequence. One of the most studied modifications is DNA methylation — the addition of methyl groups to specific sites along the genome. Methylation patterns change predictably as we age, and researchers have used these changes to build mathematical models known as epigenetic clocks.

These clocks — including the Horvath clock and newer second-generation versions like GrimAge and PhenoAge — estimate biological age from methylation data. Importantly, biological age measured this way does not always match chronological age. Two people of the same age can show meaningfully different epigenetic profiles, and that difference appears to carry some predictive value for disease risk and mortality.

Why the Distinction Between Measurement and Reversal Matters

Reducing a score on an epigenetic clock is not automatically the same as becoming biologically younger in a clinically meaningful way. The clock is a proxy — a useful and increasingly validated one, but still a model. As a result, it is important to distinguish between interventions that shift methylation patterns and those that have been proven to extend healthy human lifespan. That distinction is one the field is still working to clarify. For a broader overview of how these clocks are constructed and interpreted, see our article on how epigenetic clocks work.

What the Evidence Actually Shows

Animal Studies: Strong Signals, But Not Directly Transferable

Some of the most striking evidence for epigenetic age reversal comes from animal research. Studies in mice have demonstrated that caloric restriction, partial cellular reprogramming using Yamanaka factors, and certain pharmacological interventions can reduce epigenetic age markers and, in some cases, improve functional outcomes. These results are genuinely exciting and have shaped how researchers think about ageing.

However, animal models — particularly short-lived mice — do not always translate directly to human biology. Findings that work reliably in rodents often do not replicate at the same magnitude or in the same way in humans. This does not mean the findings are irrelevant, but it does mean they should be interpreted carefully.

Human Evidence: Preliminary but Encouraging

In humans, the evidence is more limited but growing. A small clinical trial known as the TRIIM trial found that a combination of growth hormone, DHEA, and metformin was associated with a reduction in epigenetic age as measured by the Horvath clock. The study was small and lacked a placebo control, so its conclusions remain preliminary.

Other research has found that diet quality, physical activity, sleep, and stress management are associated with epigenetic age — with healthier patterns generally corresponding to lower biological age estimates. These associations are consistent across multiple studies, though causality is difficult to confirm and effect sizes vary.

Overall, the picture that emerges is one of partial and conditional influence: epigenetic age is not fixed, but reliably reversing it in a clinically meaningful way in humans has not yet been demonstrated. Learn more in our complete guide to longevity.

How Lifestyle Factors Influence Epigenetic Age

Diet and Nutrition

Research suggests that dietary patterns influence DNA methylation in ways that may affect epigenetic age. Diets rich in vegetables, whole grains, healthy fats, and polyphenols — broadly consistent with Mediterranean-style eating — have been associated with more favourable epigenetic profiles in observational research. Conversely, diets high in processed foods and added sugars are associated with accelerated epigenetic ageing in some studies.

Caloric restriction, in particular, has shown consistent effects on epigenetic markers in animal models. Evidence in humans is more limited, but short-term fasting and structured caloric reduction have shown some associations with reduced epigenetic age in preliminary studies. The mechanisms likely involve pathways such as AMPK activation, mTOR suppression, and reduced systemic inflammation.

Exercise

Regular physical activity — particularly aerobic exercise — is consistently associated with slower epigenetic ageing in population-level research. Exercise appears to support DNA repair mechanisms, reduce oxidative stress, and improve mitochondrial function, all of which are relevant to epigenetic maintenance. In practice, even moderate activity levels appear to be beneficial compared to a sedentary lifestyle.

Sleep and Stress

Chronic poor sleep and sustained psychological stress are both associated with accelerated epigenetic ageing in observational studies. Sleep is a period of significant cellular repair and immune regulation. Disrupted sleep — particularly over long periods — appears to affect methylation patterns at sites associated with inflammation and immune function. Similarly, chronic psychological stress is associated with shorter telomeres and less favourable epigenetic profiles, likely mediated in part through elevated cortisol and inflammatory signalling.

In practice, consistent sleep quality and stress reduction strategies appear to be meaningful contributors to epigenetic health, even if the precise effect sizes in humans remain uncertain. For more on how sleep specifically supports cellular repair, see our article on whether sleep improves DNA repair.

Emerging Technologies: Reprogramming and Beyond

Partial Cellular Reprogramming

One of the most actively researched areas in ageing science is partial epigenetic reprogramming — the use of specific transcription factors (originally the Yamanaka factors, used to create induced pluripotent stem cells) to reset epigenetic patterns in aged cells without erasing their identity. In animal models, this approach has shown remarkable results, including improvements in tissue function and reductions in epigenetic age.

However, this research is still at an early stage in humans. The primary challenge is achieving targeted, controlled reprogramming without triggering tumour formation or loss of cell identity — both of which are real risks associated with this approach. Several biotechnology companies are pursuing this direction, but clinical applications in humans remain years away at minimum.

Pharmacological Approaches

Several compounds are being investigated for their potential to influence epigenetic ageing. NAD+ precursors such as NMN and NR support pathways involved in DNA repair and gene regulation, including sirtuin activity. Senolytics — drugs that selectively clear senescent cells — may reduce the inflammatory burden that accelerates epigenetic drift. Metformin, rapamycin, and other compounds that modulate AMPK and mTOR signalling are also under active investigation.

That said, none of these compounds have yet been proven to reverse epigenetic age in a clinically meaningful way in healthy humans. The science is promising, but most human evidence remains preliminary. Responsible interpretation means acknowledging that excitement and proof are not the same thing.

For a deeper look at the broader landscape of DNA repair, epigenetic drift, and what changes with age, see our hub page on DNA repair and epigenetic ageing.

References

Frequently Asked Questions

Conclusion

The evidence suggests that epigenetic age is not entirely fixed — it can be influenced by how we live, and in experimental settings, by targeted interventions at the cellular level. That is a meaningful finding. However, the gap between shifting a methylation clock score and genuinely reversing biological ageing in humans remains significant, and it is important not to overstate what current science has demonstrated.

In practice, the most well-supported approach remains a consistent commitment to lifestyle fundamentals: regular physical activity, a nutrient-dense diet, adequate sleep, and effective stress management. These factors are associated with more favourable epigenetic profiles across multiple study designs, and they carry health benefits independent of their effects on any single biomarker.

Emerging technologies — particularly partial cellular reprogramming — represent some of the most exciting directions in ageing science. However, these remain experimental. Staying informed about developments in this field is worthwhile, but the science is not yet at a stage where these approaches should be considered proven solutions.